CIK 0001880438
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
AN2 Therapeutics, Inc.
Sign in to watch- Ticker
- ANTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 820606654
- Phone
- +1 650-331-9090
- Business address
- 1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $11,602
- in 1 filing
- Open-market sales, last 90 days
- $117,428
- in 4 filings, $104K under 10b5-1 plans
Net −$105,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-07 | Readnour Robin Shane Director | Grant or award · Stock Option (right to buy) | +23,742 | 23,742 | ||
| 2023-05-15 | Easom Eric Chief Executive Officer | Purchase | +10,000 | $5.38 | $54K | 1,015,766 |
| 2023-02-23 | Easom Eric Chief Executive Officer | Grant or award · Stock Option (right to buy) | +267,650 | 267,650 | ||
| 2023-02-15 | Day Lucy Chief Financial Officer | Grant or award · Stock Option (right to buy) | +82,300 | 82,300 | ||
| 2023-02-15 | Chanda Sanjay Chief Development Officer | Grant or award · Stock Option (right to buy) | +57,950 | 57,950 | ||
| 2023-02-15 | Eckburg Paul Chief Medical Officer | Grant or award · Stock Option (right to buy) | +70,950 | 70,950 | ||
| 2023-02-15 | Eizen Joshua M Chief Legal Officer | Grant or award · Stock Option (right to buy) | +50,150 | 50,150 | ||
| 2023-02-15 | Nazak Michael Adrian Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +16,600 | 16,600 | ||
| 2023-02-15 | Krause Kevin Michael Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +62,200 | 62,200 | ||
| 2022-11-14 | Easom Eric Chief Executive Officer | Sale | −23 | $15.04 | $346 | 4,907 |
| 2022-11-10 | Easom Eric Chief Executive Officer | Sale | −4,413 | $15.32 | $68K | 4,930 |
| 2022-11-09 | Easom Eric Chief Executive Officer | Sale | −10,111 | $15.61 | $158K | 4,907 |
| 2022-11-08 | Easom Eric Chief Executive Officer | Sale | −5,800 | $15.41 | $89K | 16,273 |
| 2022-11-08 | Easom Eric Chief Executive Officer | Sale | −1,255 | $16.38 | $21K | 15,018 |
| 2022-11-07 | Easom Eric Chief Executive Officer | Sale | −10,167 | $15.90 | $162K | 6,943 |
| 2022-11-07 | Easom Eric Chief Executive Officer | Sale | −2,036 | $16.72 | $34K | 4,907 |
| 2022-11-04 | Easom Eric Chief Executive Officer | Sale | −8,828 | $15.80 | $139K | 17,110 |
| 2022-11-03 | Easom Eric Chief Executive Officer | Sale | −11,082 | $15.67 | $174K | 29,021 |
| 2022-11-03 | Easom Eric Chief Executive Officer | Sale | −3,083 | $16.02 | $49K | 25,938 |
| 2022-11-02 | Easom Eric Chief Executive Officer | Sale | −1,544 | $15.07 | $23K | 4,907 |
Page 15 of 20 · 385 trades